[HTML][HTML] Cervical cancer screening programmes and age-specific coverage estimates for 202 countries and territories worldwide: a review and synthetic analysis

L Bruni, B Serrano, E Roura, L Alemany… - The Lancet Global …, 2022 - thelancet.com
Background Cervical cancer screening coverage is a key monitoring indicator of the WHO
cervical cancer elimination plan. We present global, regional, and national cervical …

[HTML][HTML] Current cancer burden in China: epidemiology, etiology, and prevention

M Cao, H Li, D Sun, S He, X Yan, F Yang… - Cancer biology & …, 2022 - ncbi.nlm.nih.gov
Cancer has become the most common cause of death in China. Owing to rapid economic
development, improved livelihood, and shifts in risk factors, cancer epidemiology has …

Global cancer statistics 2022: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries

F Bray, M Laversanne, H Sung, J Ferlay… - CA: a cancer journal …, 2024 - Wiley Online Library
This article presents global cancer statistics by world region for the year 2022 based on
updated estimates from the International Agency for Research on Cancer (IARC). There …

[图书][B] Global strategy to accelerate the elimination of cervical cancer as a public health problem

World Health Organization - 2020 - books.google.com
Page 1 GLOBAL STRATEGY TO ACCELERATE THE ELIMINATION OF CERVICAL CANCER
AS A PUBLIC HEALTH PROBLEM Global strategy to accelerate the elimination of cervical …

[HTML][HTML] HPV vaccination introduction worldwide and WHO and UNICEF estimates of national HPV immunization coverage 2010–2019

L Bruni, A Saura-Lázaro, A Montoliu, M Brotons… - Preventive …, 2021 - Elsevier
Abstract WHO/UNICEF estimates for HPV vaccination coverage from 2010 to 2019 are
analyzed against the backdrop of the 90% coverage target for HPV vaccination by 2030 set …

[图书][B] WHO guideline for screening and treatment of cervical pre-cancer lesions for cervical cancer prevention: Use of mRNA Tests for Human Papillomavirus (HPV)

World Health Organization - 2021 - books.google.com
Page 1 WHO guideline for screening and treatment of cervical pre-cancer lesions for cervical
cancer prevention, second edition: use of mRNA tests for human papillomavirus (HPV) Page …

[HTML][HTML] Vaccine efficacy against persistent human papillomavirus (HPV) 16/18 infection at 10 years after one, two, and three doses of quadrivalent HPV vaccine in …

P Basu, SG Malvi, S Joshi, N Bhatla… - The Lancet …, 2021 - thelancet.com
Background A randomised trial designed to compare three and two doses of quadrivalent
human papillomavirus (HPV) vaccine in adolescent girls in India was converted to a cohort …

Targeting cancer-promoting inflammation—have anti-inflammatory therapies come of age?

J Hou, M Karin, B Sun - Nature reviews Clinical oncology, 2021 - nature.com
The immune system has crucial roles in cancer development and treatment. Whereas
adaptive immunity can prevent or constrain cancer through immunosurveillance, innate …

[HTML][HTML] Mortality impact of achieving WHO cervical cancer elimination targets: a comparative modelling analysis in 78 low-income and lower-middle-income countries

K Canfell, JJ Kim, M Brisson, A Keane, KT Simms… - The Lancet, 2020 - thelancet.com
Background WHO is developing a global strategy towards eliminating cervical cancer as a
public health problem, which proposes an elimination threshold of four cases per 100 000 …

Global cancer statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries

H Sung, J Ferlay, RL Siegel… - CA: a cancer journal …, 2021 - Wiley Online Library
This article provides an update on the global cancer burden using the GLOBOCAN 2020
estimates of cancer incidence and mortality produced by the International Agency for …